Screener
Veracyte VCYT Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $263,136 | $362,578 |
| Short-term investments | 175,924 | 50,311 |
| Accounts receivable | 50,112 | 44,660 |
| Supplies | 21,416 | 20,546 |
| Prepaid expenses and other current assets | 11,587 | 10,281 |
| Total current assets | 522,175 | 488,376 |
| Property, plant and equipment, net | 22,652 | 22,192 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's accounts receivable?
- Veracyte (VCYT) reported accounts receivable of $50.11M in Q1 2026.
- How has Veracyte's accounts receivable changed year-over-year?
- Veracyte's accounts receivable decreased by 6.8% year-over-year, from $53.78M to $50.11M.
- What is the long-term trend for Veracyte's accounts receivable?
- Over 5 years (2020 to 2025), Veracyte's accounts receivable has grown at a 19.3% compound annual growth rate (CAGR), from $18.46M to $44.66M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Veracyte's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude